NASDAQ:IOVA (Iovance Biotherapeutics, Inc.)

About IOVA

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Latest News

    No posts found.